102 related articles for article (PubMed ID: 15627064)
1. Anticancer activity of aconitine-containing herbal extract BC1.
Solyanik GI; Fedorchuk AG; Pyaskovskaya ON; Dasyukevitch OI; Khranovskaya NN; Aksenov GN; Sobetsky VV
Exp Oncol; 2004 Dec; 26(4):307-11. PubMed ID: 15627064
[TBL] [Abstract][Full Text] [Related]
2. Influence of aconitine-containing herbal extract BC1 on proliferative and electrokinetic characteristics of endothelial cells.
Garmanchouk LV; Pyaskovskaya ON; Yanish YV; Shlyakhovenko VA; Dasyukevich OI; Solyanik GI
Exp Oncol; 2005 Dec; 27(4):262-6. PubMed ID: 16404344
[TBL] [Abstract][Full Text] [Related]
3. Changes in VEGF level and tumor growth characteristics during lewis lung carcinoma progression towards cis-DDP resistance.
Pyaskovskaya ON; Dasyukevich OI; Kolesnik DL; Garmanchouk LV; Todor IN; Solyanik GI
Exp Oncol; 2007 Sep; 29(3):197-202. PubMed ID: 18004244
[TBL] [Abstract][Full Text] [Related]
4. Total flavonoids of Daphne genkwa root significantly inhibit the growth and metastasis of Lewis lung carcinoma in C57BL6 mice.
Zheng W; Gao X; Chen C; Tan R
Int Immunopharmacol; 2007 Feb; 7(2):117-27. PubMed ID: 17178377
[TBL] [Abstract][Full Text] [Related]
5. Antitumor and antimetastatic activities of 4-hydroxyderricin isolated from Angelica keiskei roots.
Kimura Y; Taniguchi M; Baba K
Planta Med; 2004 Mar; 70(3):211-9. PubMed ID: 15114497
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants.
Pyaskovskaya ON; Sorokina LV; Kolesnik DL; Boichuk IV; Melnikov OR; Solyanik GI
Exp Oncol; 2014 Mar; 36(1):29-33. PubMed ID: 24691281
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of anticancer efficacy of aonitine-containing agent BC1 against ascite and solid forms of Ehrlich's carcinoma.
Dasyukevich OI; Solyanik GI
Exp Oncol; 2007 Dec; 29(4):317-9. PubMed ID: 18199991
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of tumor growth and tumor metastasis by a Chinese herbal formula--ZYD88, in an animal model with metastatic Lewis lung carcinoma.
Duan YW; Huang Y; Cai LQ; Duan Q; Zhu YS
Oncol Rep; 2007 Jun; 17(6):1391-7. PubMed ID: 17487396
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy to a primary tumor accelerates metastatic growth in mice.
Camphausen K; Moses MA; Beecken WD; Khan MK; Folkman J; O'Reilly MS
Cancer Res; 2001 Mar; 61(5):2207-11. PubMed ID: 11280788
[TBL] [Abstract][Full Text] [Related]
10. Effect of dichloroacetate on Lewis lung carcinoma growth and metastasis.
Kolesnik DL; Pyaskovskaya ON; Boychuk IV; Dasyukevich OI; Melnikov OR; Tarasov AS; Solyanik GI
Exp Oncol; 2015 Jun; 37(2):126-9. PubMed ID: 26112940
[TBL] [Abstract][Full Text] [Related]
11. Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells.
Kim JH; Lee EO; Lee HJ; Ku JS; Lee MH; Yang DC; Kim SH
Ann N Y Acad Sci; 2006 Dec; 1090():147-60. PubMed ID: 17384257
[TBL] [Abstract][Full Text] [Related]
12. GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions.
Pan Y; Song QL; Lin YH; Lu N; Yu HM; Li XJ
Acta Pharmacol Sin; 2005 Jul; 26(7):881-6. PubMed ID: 15960897
[TBL] [Abstract][Full Text] [Related]
13. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
14. [The primary evaluation of Sal-Ammoniac extract on the therapy action in mice bearing Lewis lung cancer].
Han XF; Du GJ; Lin HH; Song ZH; Wang M; Zhang S
Zhong Yao Cai; 2008 Feb; 31(2):245-8. PubMed ID: 18619270
[TBL] [Abstract][Full Text] [Related]
15. Study of photodynamic efficiency of the hematoporphyrin conjugated with antibody to VEGF in mouse Lewis carcinoma.
Novichenko NL; Mamchur AA; Lisniak IO; Gamaliya MF
Exp Oncol; 2008 Dec; 30(4):315-8. PubMed ID: 19112430
[TBL] [Abstract][Full Text] [Related]
16. Effect of prostaglandin E2-producing nonmetastatic Lewis lung carcinoma cells on the migration of prostaglandin E2-responsive metastatic Lewis lung carcinoma cells.
Young MR; Young ME; Wepsic HT
Cancer Res; 1987 Jul; 47(14):3679-83. PubMed ID: 3109729
[TBL] [Abstract][Full Text] [Related]
17. MAPK regulation and caspase activation are required in DMNQ S-52 induced apoptosis in Lewis lung carcinoma cells.
Lee SJ; Sakurai H; Koizumi K; Song GY; Bae YS; Kim HM; Kang KS; Surh YJ; Saiki I; Kim SH
Cancer Lett; 2006 Feb; 233(1):57-67. PubMed ID: 15893420
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of murine Lewis lung cancer with recombinant interleukin-12].
Yin XL; Duan H; Peng ZP; Sun SL; Li SL
Ai Zheng; 2006 Sep; 25(9):1087-91. PubMed ID: 16965647
[TBL] [Abstract][Full Text] [Related]
19. [Lewis lung carcinoma variant with high sensitivity to antitumor antiangiogenic therapy reveals a high capacity to autophagy].
Kolesnyk DL; Piaskovs'ka OM; Tregubova NA; Solianyk HI
Tsitol Genet; 2012; 46(3):33-40. PubMed ID: 22856144
[TBL] [Abstract][Full Text] [Related]
20. Association of a functional prostaglandin E2-protein kinase A coupling with responsiveness of metastatic Lewis lung carcinoma variants to prostaglandin E2 and to prostaglandin E2-producing nonmetastatic Lewis lung carcinoma variants.
Young MR; Duffie GP; Lozano Y; Young ME; Wright MA
Cancer Res; 1990 May; 50(10):2973-8. PubMed ID: 2159367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
